genedx.com - WGS Income before deduction of interest, taxes and amortization
High levels of robotics and AI implementation are optimizing genome analysis, which is reflected in the monetary expression of EBITDA. The value of 0.00 indicates the level of this parameter. The business relies on non-cyclical demand for diagnostics, which remains resilient during crises. Currently, GeneDx Holdings Corp. is prioritizing organic growth and scientific alliances, temporarily pivoting away from aggressive mergers to focus on profitability.
GeneDx Holdings Corp. (WGS) - metric breakdowns and financial figures
- share price and expert price forecast:
- issuer market value details:
- book capitalization information:
- business debt structure and liquidity details:
- earnings and market ratios statistics:
WGS - Company Net Income|Company Profit Forecast GeneDx Holdings Corp.|WGS - Price to Earnings Ratio|Future Price to Earnings Multiple GeneDx|WGS - PEG Multiple|Enterprise Value to EBITDA Ratio GeneDx Holdings Corp.|WGS - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months GeneDx|WGS - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months genedx.com|WGS - Earnings per share growth in current year|Net earnings per share change forecast for next year GeneDx Holdings Corp.
- sales and revenue data:
Summary company analytics:WGS genedx.com
It is critical for investors to mitigate the risk of overpaying for an asset by analyzing the absolute EBITDA level to determine the real cash flow from core operations, which measures the business's ability to generate cash before depreciation and taxes. Explosive demand for genomic sequencing is accelerating the ARR of GeneDx Holdings Corp. (WGS), transforming operational resilience into a foundation for profitability and confirming the high reliability of the business model.
Competitors of GeneDx Holdings Corp. (WGS)
Operating income before deduction of amortization Tempus AI Inc (TEM)|QGEN - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization IONS (Ionis Pharmaceuticals, Inc.)|RGEN: Operating profit EBITDA|Avidity - Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization CRSP|Operating profit before amortization RARE (Ultragenyx)|Profit before payment of interest, taxes and amortization Beam Therapeutics (BEAM)|Company profit before taxes, interest and amortization SRPT|Profit before payment of interest, taxes and amortization Twist Bioscience Corp TWST|Operating income before deduction of amortization 10x Genomics, Inc. (TXG)|Intellia Therapeutics - Operating profit EBITDA|STOK - Operating profit EBITDA|BLFS (biolifesolutions.com) - Operating profit before deduction of amortization|WVE - Operating income before deduction of amortization|Operating profit before deduction of amortization MAZE|Sionna Pharma - Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA PRME|TSHA (Taysha Gene Therapies) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization uniQure QURE|MGTX: Operating profit before amortization|REGENXBIO Inc - Operating profit EBITDA|Profit before interest, taxes and amortization Solid Corp|Ocugen (OCGN) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Pacific Biosciences|Operating profit before deduction of amortization BNTC|Operating profit before deduction of amortization Design Therapeutics Inc (DSGN)|Operating profit EBITDA RCKT|Operating profit EBITDA 4D Molecular Therapeutics, Inc. (FDMT)|lexeotx.com - Operating profit before deduction of amortization|KRRO: Operating profit before amortization|Editas Corp - Operating profit EBITDA|SLN: Profit before payment of interest, taxes and amortization|PRQR (ProQR) - Operating profit before deduction of amortization|Operating profit before amortization CDXS|Profit before payment of interest, taxes and amortization sangamo.com|Operating profit before amortization NAUT (Nautilus Biotechnology)|Operating profit EBITDA MGX|Operating income before deduction of amortization Precision BioSciences Inc.|Operating profit EBITDA GBIO (Generation Bio Co)|Operating profit EBITDA Boundless Bio, Inc BOLD|Exicure Corp - Operating profit EBITDA|Operating income before deduction of amortization Imunon IMNN|PHIO: Operating profit EBITDA|MBIO: Company profit before taxes, interest and amortization|Profit before payment of interest, taxes and amortization TransCode Therapeutics, Inc.|Operating profit EBITDA Bionano Genomics, Inc.|Profit before payment of interest, taxes and amortization Applied DNA (APDN)|Profit before payment of interest, taxes and amortization BLUE (bluebird bio, Inc.)|Operating profit EBITDA IPA (immunoprecise.com)|Operating profit EBITDA Omega OMGA|OMIC - Profit before payment of interest, taxes and amortization|RGLS - Operating profit EBITDA|Syros Pharmaceuticals Inc. (SYRS) - Profit before payment of interest, taxes and amortization|TBIO (Telesis Bio, Inc.) - Profit before payment of interest, taxes and amortization|TCON (TRACON Pharmaceuticals Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization Unity Bio UBX
